Please login to the form below

Not currently logged in
Email:
Password:

antbody-drug conjugates

This page shows the latest antbody-drug conjugates news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA furthers antibody ambitions in cancer

Merck KGaA furthers antibody ambitions in cancer

Signs deal with Mersana to develop antibody-drug conjugates. Germany's Merck KGaA is keeping the pressure on its rivals in oncology by signing a deal with US-based biotech Mersana ... Merck, via its biopharma division Merck Serono, will use Mersana's

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics